Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -20.95%2.66M | 70.38%4.87M | -74.49%2.95M | -72.13%14.6M | -88.11%2.16M | -32.83%3.36M | -77.63%2.86M | -29.71%11.56M | -7.96%52.39M | 9.70%18.16M |
| Cost of revenue | 32.97%4.39M | -4.77%2.56M | -75.70%2.74M | -72.25%14.21M | -88.86%2.08M | -29.03%3.3M | -77.72%2.68M | -28.65%11.26M | -3.59%51.2M | 14.68%18.71M |
| Gross profit | -3,145.61%-1.74M | 1,216.48%2.32M | -28.38%212K | -66.64%396K | 113.31%74K | -83.62%57K | -76.09%176K | -55.08%296K | -68.85%1.19M | -337.61%-556K |
| Operating expense | -93.32%921K | 122.94%3.6M | -25.62%2.21M | -42.57%4.67M | 22.66%3.65M | 834.21%13.79M | -6.06%1.61M | 52.00%2.97M | -18.67%8.12M | -32.26%2.98M |
| Selling and administrative expenses | -22.41%921K | -41.59%1.37M | -34.63%1.01M | -42.57%4.67M | -24.98%1.67M | -20.07%1.19M | 48.98%2.34M | -17.47%1.55M | -18.67%8.12M | -50.09%2.22M |
| -Selling and marketing expense | --0 | --0 | --0 | --0 | -103.06%-3K | --0 | -87.80%20K | -34.15%81K | --498K | 118.99%98K |
| -General and administrative expense | -22.41%921K | -41.09%1.37M | -31.01%1.01M | -38.81%4.67M | -21.37%1.67M | -13.48%1.19M | 64.91%2.32M | -16.30%1.46M | -23.66%7.63M | -57.25%2.12M |
| Other operating expenses | ---- | --2.23M | -15.82%1.2M | 1,470.61%15.28M | 162.48%1.99M | --12.6M | ---- | 1,677.50%1.42M | --973K | --757K |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | --729K | ---- | ---- | ---- |
| Operating profit | 80.65%-2.66M | 11.00%-1.28M | 25.31%-2M | 38.45%-4.27M | -1.27%-3.58M | -1,117.38%-13.73M | -46.48%-1.44M | -106.57%-2.67M | -12.27%-6.94M | 15.11%-3.54M |
| Net non-operating interest income (expenses) | -2K | 99.77%-1K | 0 | 100.25%5K | -37.94%-629K | 0 | 18.63%-428K | 20.32%-404K | 26.07%-1.99M | 19.01%-456K |
| Non-operating interest income | ---- | ---- | ---- | 0.00%9K | ---- | ---- | ---- | ---- | -52.63%9K | ---- |
| Non-operating interest expense | --2K | -99.77%1K | --0 | -99.80%4K | 37.94%629K | --0 | -18.63%428K | -20.32%404K | -26.25%2M | -21.65%456K |
| Net investment income | -99.25%2K | 74.03%268K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 47.67%127K | 86K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -56.86%387K | 182.97%897K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | ---387K | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -182.97%-897K | ---- |
| Other non-operating income (expenses) | -22.63%1.28M | -74.24%17K | -94.18%32K | 1,956.92%2.67M | -47.27%405K | 214.26%1.65M | 37.50%66K | 1,045.83%550K | -3.70%130K | 2,121.05%768K |
| Income before tax | 88.58%-1.38M | 29.79%-1.26M | 22.26%-1.96M | 50.32%-3.75M | -18.03%-3.8M | -985.27%-12.08M | -23.30%-1.8M | -44.12%-2.53M | 8.70%-7.55M | 24.94%-3.22M |
| Income tax | 0 | 0 | 0 | 0 | 389.29%81K | 3.70%-26K | 0.00%-27K | -3.70%-28K | -475.86%-109K | -125.00%-28K |
| Net income | 88.55%-1.38M | 28.72%-1.26M | 21.39%-1.96M | 49.60%-3.75M | -21.60%-3.89M | -1,009.85%-12.05M | -23.74%-1.77M | -44.75%-2.5M | 10.33%-7.44M | 27.49%-3.2M |
| Net income continuous operations | 88.55%-1.38M | 28.72%-1.26M | 21.39%-1.96M | 49.60%-3.75M | -21.60%-3.89M | -1,009.85%-12.05M | -23.74%-1.77M | -44.75%-2.5M | 10.33%-7.44M | 27.49%-3.2M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 88.55%-1.38M | 28.72%-1.26M | 21.39%-1.96M | 49.60%-3.75M | -21.60%-3.89M | -1,009.85%-12.05M | -23.74%-1.77M | -44.75%-2.5M | 10.33%-7.44M | 27.49%-3.2M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 88.55%-1.38M | 28.72%-1.26M | 21.39%-1.96M | 49.60%-3.75M | -21.60%-3.89M | -1,009.85%-12.05M | -23.74%-1.77M | -44.75%-2.5M | 10.33%-7.44M | 27.49%-3.2M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 109.85%0.0013 | 36.84%-0.0012 | 22.22%-0.0021 | 49.38%-0.0041 | -20.00%-0.0042 | -1,000.00%-0.0132 | -18.75%-0.0019 | -42.11%-0.0027 | 10.99%-0.0081 | 30.00%-0.0035 |
| Diluted earnings per share | 109.85%0.0013 | 36.84%-0.0012 | 22.22%-0.0021 | 49.38%-0.0041 | -20.00%-0.0042 | -1,000.00%-0.0132 | -18.75%-0.0019 | -42.11%-0.0027 | 10.99%-0.0081 | 30.00%-0.0035 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.